Stephen R Viess, MD
Sports Medicine · Pleasanton
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 9
- 1 carrier
- Offices
- 3
On the public record
- Owns San Ramon Surgery Center, LP: Accreditation Lapsed
Offices
3 locations · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Viess’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A71570 · Current
Licensed to practise in California · since 2000 · expires 2028-04-30 · Rosalind Franklin University, the Chicago Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- San Ramon Surgery Center, LPAmbulatory Surgery Center · San Ramon, CA2.63% owner since 2007 · accredited by AAAHCAccreditation Lapsed2 inspections, 2 with deficiencies · last 2015-09-29: Requirements Met
- Pleasanton Surgery Center, LLCAmbulatory Surgery Center · Pleasanton, CA11.6% owner since 2018 · accredited by IMQAccreditation Renewed3 inspections, 2 with deficiencies · last 2018-07-23: Requirements Met
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$155,653
Medicare paid this office $155,653 for 484 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 289 | $45,597 | $116 |
| Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | 53 | $21,431 | None |
| Short return visit (20+ min) | 140 | $18,195 | $81 |
| New patient visit (30+ min) | 182 | $17,476 | $96 |
| Aspiration and/or injection of fluid from large joint | 155 | $12,688 | $66 |
See all 8 services
| Return visit (30+ min) | 289 | $45,597 | $116 |
| Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | 53 | $21,431 | None |
| Short return visit (20+ min) | 140 | $18,195 | $81 |
| New patient visit (30+ min) | 182 | $17,476 | $96 |
| Aspiration and/or injection of fluid from large joint | 155 | $12,688 | $66 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 101 | $430 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 67 | $30 | None |
| Injection, bupivicaine, not otherwise specified, 0.5 mg | 71 | $22 | None |
Procedures Medicare counted
| Lower limb (leg) arthroscopy (minimally invasive joint repair) | 21 | More than 93% of doctors who do this |
| Upper limb (arm) arthroscopy (minimally invasive joint repair) | 27 | More than 71% of doctors who do this |
Who their Medicare patients are
484 Original Medicare patients in 2024. Average age 74 · Under 65 6% · 85 and older 10% · Women 55% · Also on Medicaid 13% · Health risk score 1.17. Above the middle of the specialty; the typical sports medicine clinician is at 1.05.
Conditions among them: High blood pressure 69% · Chronic kidney disease 28% · Diabetes 25% · Coronary heart disease 22% · Depression 18% · Cancer 17% · Atrial fibrillation 17% · Heart failure 11% · COPD 11% · Dementia 5% · Stroke 4%.
The office billed $1,081,295, Medicare allowed $204,865 and paid $155,653; for 9,243 services of 37 kinds; $24,633 of it was for drugs given in the office and $131,020 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 484 | 9,243 | 74 | 1.17 | $1,081,295 | $155,653 |
| 2023 | 428 | 6,101 | 74 | 1.08 | $912,145 | $155,043 |
| 2022 | 360 | 7,273 | 74 | 1.00 | $933,232 | $172,486 |
| 2021 | 301 | 7,337 | 73 | 1.08 | $807,251 | $172,880 |
| 2020 | 292 | 7,323 | 74 | 1.21 | $643,551 | $171,199 |
| 2019 | 437 | 8,098 | 75 | 1.21 | $912,755 | $199,772 |
| 2018 | 430 | 5,286 | 74 | 1.19 | $874,549 | $189,053 |
| 2017 | 421 | 7,798 | 75 | 1.18 | $856,254 | $186,389 |
| 2016 | 412 | 7,060 | 74 | 1.18 | $866,689 | $173,625 |
| 2015 | 386 | 5,342 | 74 | 1.16 | $720,406 | $152,898 |
| 2014 | 289 | 3,903 | 74 | 1.20 | $508,251 | $112,217 |
| 2013 | 305 | 4,233 | 73 | 1.23 | $613,896 | $129,342 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Return visit (30+ min) | 242 | $42,110 | $116 |
| Short return visit (20+ min) | 163 | $19,324 | $82 |
| Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | 44 | $17,351 | None |
| Repair of shoulder rotator cuff using an endoscope | 14 | $13,973 | $998 |
| Aspiration and/or injection of fluid from large joint | 155 | $13,267 | $65 |
| New patient visit (30+ min) | 127 | $12,795 | $101 |
| Telehealth originating site facility fee | 48 | $1,145 | $22 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 126 | $620 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 83 | $43 | None |
2022: 8 services
| Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | 54 | $43,837 | None |
| Return visit (30+ min) | 216 | $39,261 | $116 |
| Aspiration and/or injection of fluid from large joint | 172 | $16,833 | $61 |
| Short return visit (20+ min) | 118 | $14,914 | $81 |
| New patient visit (30+ min) | 128 | $10,796 | $84 |
| Telehealth originating site facility fee | 50 | $1,047 | $20 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 129 | $757 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 97 | $56 | None |
2021: 13 services
| Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | 51 | $65,363 | None |
| Return visit (30+ min) | 162 | $27,506 | $113 |
| Aspiration and/or injection of fluid from large joint | 155 | $14,853 | $63 |
| Short return visit (20+ min) | 126 | $14,711 | $80 |
| Repair of shoulder rotator cuff using an endoscope | 11 | $10,868 | $988 |
| New patient visit (30+ min) | 89 | $8,383 | $94 |
| New patient visit (45+ min) | 23 | $3,324 | $145 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 13 | $1,160 | $89 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 116 | $727 | None |
| X-ray of both knees while standing | 15 | $566 | $38 |
| X-ray of knee, 1-2 views | 16 | $537 | $27 |
| Telehealth originating site facility fee | 18 | $411 | $22 |
| Injection, dexamethasone sodium phosphate, 1 mg | 88 | $65 | None |
2020: 16 services
| Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | 46 | $67,507 | None |
| Return visit (30+ min) | 182 | $28,902 | $100 |
| Aspiration and/or injection of fluid from large joint | 134 | $14,939 | $62 |
| Short return visit (20+ min) | 128 | $11,048 | $61 |
| Mri scan of leg joint without contrast | 25 | $4,861 | $162 |
| New patient visit (45+ min) | 25 | $3,901 | $156 |
| Mri scan of arm joint without contrast | 15 | $2,498 | $156 |
| New patient visit (30+ min) | 32 | $2,462 | $77 |
| X-ray of knee, 1-2 views | 63 | $2,420 | $33 |
| X-ray of both knees while standing | 61 | $2,325 | $38 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $2,037 | $185 |
| X-ray of shoulder, minimum of 2 views | 42 | $1,601 | $31 |
| X-ray of hip, 2-3 views | 23 | $1,174 | $45 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 113 | $937 | None |
| Telephone medical discussion with physician, 5-10 minutes | 12 | $583 | $45 |
| Injection, dexamethasone sodium phosphate, 1 mg | 87 | $58 | None |
2019: 18 services
| Short return visit (20+ min) | 246 | $29,286 | $68 |
| Aspiration and/or injection of fluid from large joint | 224 | $24,627 | $60 |
| Return visit (30+ min) | 193 | $23,036 | $100 |
| Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | 56 | $21,715 | None |
| Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | 18 | $20,263 | None |
| New patient visit (30+ min) | 108 | $10,527 | $97 |
| Mri scan of leg joint without contrast | 45 | $8,952 | $172 |
| Mri scan of arm joint without contrast | 35 | $5,944 | $165 |
| X-ray of knee, 1-2 views | 92 | $3,581 | $32 |
| X-ray of both knees while standing | 91 | $3,510 | $38 |
| X-ray of shoulder, minimum of 2 views | 68 | $2,845 | $31 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,465 | $176 |
| Mri scan of lower spinal canal without contrast | 14 | $2,090 | $149 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 180 | $1,701 | None |
| X-ray of hip, 2-3 views | 21 | $880 | $42 |
| X-ray of pelvis, 1-2 views | 18 | $809 | $34 |
| Injection, methylprednisolone acetate, 40 mg | 21 | $422 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 129 | $65 | None |
2018: 18 services
| Return visit (30+ min) | 243 | $32,607 | $96 |
| Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | 39 | $24,212 | None |
| Aspiration and/or injection of fluid from large joint | 185 | $19,832 | $59 |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 25 | $15,480 | None |
| Short return visit (20+ min) | 161 | $14,612 | $63 |
| Mri scan of leg joint without contrast | 63 | $11,747 | $163 |
| New patient visit (30+ min) | 96 | $9,148 | $95 |
| Mri scan of arm joint without contrast | 27 | $4,869 | $168 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 21 | $3,781 | $180 |
| X-ray of knee, 1-2 views | 93 | $3,474 | $30 |
| X-ray of both knees while standing | 92 | $3,312 | $35 |
| Mri scan of lower spinal canal without contrast | 17 | $2,331 | $137 |
| X-ray of shoulder, minimum of 2 views | 59 | $1,931 | $28 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 138 | $1,586 | None |
| X-ray of hip, 2-3 views | 31 | $1,543 | $42 |
| X-ray of ankle, minimum of 3 views | 12 | $537 | $30 |
| Injection, methylprednisolone acetate, 40 mg | 25 | $223 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 115 | $70 | None |
2017: 19 services
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 52 | $39,136 | None |
| Return visit (30+ min) | 207 | $25,468 | $92 |
| Aspiration and/or injection of fluid from large joint | 216 | $19,551 | $55 |
| Short return visit (20+ min) | 171 | $17,285 | $62 |
| New patient visit (30+ min) | 106 | $9,676 | $91 |
| Mri scan of leg joint without contrast | 56 | $9,618 | $160 |
| Mri scan of arm joint without contrast | 32 | $5,373 | $145 |
| X-ray of knee, 1-2 views | 92 | $3,636 | $29 |
| X-ray of both knees while standing | 88 | $3,247 | $35 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,776 | $174 |
| X-ray of shoulder, minimum of 2 views | 68 | $2,322 | $27 |
| Mri scan of lower spinal canal without contrast | 13 | $1,779 | $137 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 171 | $1,694 | None |
| X-ray of pelvis, 1-2 views | 27 | $1,100 | $30 |
| X-ray of hip, 2-3 views | 22 | $848 | $35 |
| X-ray of ankle, minimum of 3 views | 12 | $513 | $30 |
| X-ray of foot, minimum of 3 views | 12 | $499 | $28 |
| Injection, methylprednisolone acetate, 40 mg | 25 | $163 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 151 | $73 | None |
2016: 20 services
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 51 | $34,099 | None |
| Return visit (30+ min) | 195 | $19,348 | $83 |
| Short return visit (20+ min) | 197 | $18,190 | $58 |
| Aspiration and/or injection of fluid from large joint | 189 | $16,589 | $53 |
| Mri scan of leg joint without contrast | 64 | $11,221 | $156 |
| New patient visit (30+ min) | 103 | $8,744 | $85 |
| Mri scan of arm joint without contrast | 31 | $4,922 | $159 |
| X-ray of knee, 1-2 views | 106 | $3,833 | $28 |
| X-ray of both knees while standing | 104 | $3,602 | $32 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,251 | $161 |
| X-ray of shoulder, minimum of 2 views | 60 | $1,855 | $24 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 150 | $1,448 | None |
| X-ray of wrist, minimum of 3 views | 16 | $756 | $30 |
| X-ray of ankle, minimum of 3 views | 16 | $705 | $26 |
| X-ray of foot, minimum of 3 views | 19 | $602 | $23 |
| X-ray of hip, 2-3 views | 13 | $491 | $38 |
| X-ray of elbow, minimum of 3 views | 13 | $424 | $28 |
| X-ray of hip, 1 view | 12 | $295 | $25 |
| Injection, methylprednisolone acetate, 40 mg | 23 | $115 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 123 | $78 | None |
2015: 20 services
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 31 | $20,225 | None |
| Short return visit (20+ min) | 181 | $18,782 | $60 |
| Return visit (30+ min) | 174 | $18,634 | $89 |
| Aspiration and/or injection of fluid from large joint | 168 | $14,478 | $53 |
| New patient visit (30+ min) | 108 | $9,523 | $88 |
| Mri scan of leg joint without contrast | 46 | $9,070 | $189 |
| Mri scan of arm joint without contrast | 31 | $6,120 | $185 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $3,093 | $172 |
| X-ray of knee, 1-2 views | 74 | $2,545 | $26 |
| X-ray of both knees while standing | 73 | $2,288 | $29 |
| X-ray of shoulder, minimum of 2 views | 50 | $1,781 | $26 |
| X-ray of ribs of one side of body, minimum of 2 views | 34 | $1,586 | $34 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 145 | $1,275 | None |
| X-ray of pelvis, 1-2 views | 36 | $1,221 | $25 |
| X-ray of foot, minimum of 3 views | 22 | $971 | $25 |
| X-ray of ankle, minimum of 3 views | 22 | $902 | $27 |
| X-ray of wrist, minimum of 3 views | 11 | $692 | $33 |
| Short return visit | 11 | $473 | $39 |
| Injection, dexamethasone sodium phosphate, 1 mg | 127 | $79 | None |
| Injection, methylprednisolone acetate, 40 mg | 14 | $62 | None |
2014: 17 services
| Short return visit (20+ min) | 156 | $16,912 | $59 |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 24 | $14,189 | None |
| Return visit (30+ min) | 102 | $10,398 | $89 |
| Aspiration and/or injection of fluid from large joint | 113 | $10,347 | $46 |
| New patient visit (30+ min) | 86 | $7,227 | $84 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $3,302 | $174 |
| Mri scan of arm joint without contrast | 17 | $3,018 | $178 |
| Mri scan of leg joint without contrast | 16 | $2,550 | $159 |
| X-ray of knee, 1-2 views | 57 | $2,165 | $29 |
| X-ray of both knees while standing | 52 | $1,793 | $34 |
| X-ray of shoulder, minimum of 2 views | 39 | $1,478 | $28 |
| X-ray of ankle, minimum of 3 views | 15 | $919 | $30 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 99 | $908 | None |
| X-ray of ribs of one side of body, minimum of 2 views | 17 | $697 | $37 |
| X-ray of pelvis, 1-2 views | 25 | $696 | $25 |
| X-ray of foot, minimum of 3 views | 11 | $499 | $29 |
| Injection, dexamethasone sodium phosphate, 1 mg | 76 | $50 | None |
2013: 17 services
| Short return visit (20+ min) | 181 | $19,952 | $60 |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 24 | $15,335 | None |
| Return visit (30+ min) | 113 | $11,571 | $87 |
| Aspiration and/or injection of fluid from large joint | 110 | $9,265 | $44 |
| Mri scan of leg joint without contrast | 27 | $6,219 | $207 |
| New patient visit (30+ min) | 74 | $6,157 | $83 |
| Mri scan of arm joint without contrast | 19 | $3,866 | $193 |
| X-ray of knee, 1-2 views | 78 | $3,621 | $29 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $2,996 | $166 |
| X-ray of both knees while standing | 75 | $2,717 | $32 |
| X-ray of shoulder, minimum of 2 views | 54 | $2,009 | $28 |
| X-ray of ribs of one side of body, minimum of 2 views | 25 | $1,213 | $38 |
| X-ray of ankle, minimum of 3 views | 19 | $1,155 | $31 |
| X-ray of pelvis, 1-2 views | 29 | $1,051 | $27 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 99 | $859 | None |
| X-ray of foot, minimum of 3 views | 11 | $639 | $29 |
| Injection, dexamethasone sodium phosphate, 1 mg | 72 | $46 | None |
Drugs they prescribed that Part D paid
$442
Pharmacies billed $442 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 45% of their Part D prescriptions (22 of 49) in 2024. Too few prescriptions to compare fairly with other clinicians.
49 generic and 0 brand-name prescriptions · $442 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Hydrocodone-Acetaminophen | 12 | $101 | $8 |
| Methylprednisolone | 12 | $70 | $6 |
Year by year
| 2024 | 49 | 39 | 45% (22) | 0% | $442 |
| 2023 | 49 | 38 | 31% (15) | None | $829 |
| 2022 | 129 | 48 | 49% (63) | 0% | $2,005 |
| 2021 | 180 | 48 | 48% (87) | None | $4,576 |
| 2020 | 266 | 69 | 54% (143) | None | $6,199 |
| 2019 | 259 | 75 | 43% (111) | None | $6,258 |
| 2018 | 223 | 79 | 53% (119) | 6% | $6,302 |
| 2017 | 156 | 65 | 56% (88) | None | $6,236 |
| 2016 | 128 | 55 | 63% (80) | None | $6,585 |
| 2015 | 143 | 61 | 65% (93) | None | $8,274 |
| 2014 | 226 | 67 | 71% (160) | None | $11,564 |
| 2013 | 224 | 71 | 59% (133) | 6% | $9,543 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Methylprednisolone | 14 | $140 | $10 |
2022: 4 drugs
| Hydrocodone-Acetaminophen | 33 | $476 | $14 |
| Oxycodone-Acetaminophen | 20 | $355 | $18 |
| Methylprednisolone | 11 | $76 | $7 |
| Zolpidem | 13 | $27 | $2 |
2021: 6 drugs
| Hydrocodone-Acetaminophen | 54 | $1,699 | $31 |
| Diclofenac | 25 | $458 | $18 |
| Oxycodone-Acetaminophen | 20 | $290 | $14 |
| Ibuprofen | 11 | $150 | $14 |
| Zolpidem | 11 | $138 | $13 |
| Tramadol | 12 | $46 | $4 |
2020: 7 drugs
| Hydrocodone-Acetaminophen | 90 | $2,949 | $33 |
| Diclofenac | 41 | $1,241 | $30 |
| Oxycodone-Acetaminophen | 30 | $554 | $18 |
| Zolpidem | 14 | $126 | $9 |
| Omeprazole | 17 | $125 | $7 |
| Acetaminophen-Codeine | 14 | $81 | $6 |
| Lorazepam | 12 | $37 | $3 |
2019: 7 drugs
| Hydrocodone-Acetaminophen | 76 | $2,407 | $32 |
| Diclofenac | 31 | $1,154 | $37 |
| Oxycodone-Acetaminophen | 15 | $594 | $40 |
| Omeprazole | 22 | $166 | $8 |
| Methylprednisolone | 11 | $156 | $14 |
| Lorazepam | 15 | $85 | $6 |
| Tramadol | 13 | $44 | $3 |
2018: 5 drugs
| Hydrocodone-Acetaminophen | 76 | $2,494 | $33 |
| Oxycodone-Acetaminophen | 21 | $714 | $34 |
| Diclofenac | 17 | $399 | $23 |
| Methylprednisolone | 12 | $164 | $14 |
| Tramadol | 14 | $50 | $4 |
2017: 2 drugs
| Hydrocodone-Acetaminophen | 61 | $1,236 | $20 |
| Oxycodone-Acetaminophen | 16 | $430 | $27 |
2016: 2 drugs
| Hydrocodone-Acetaminophen | 58 | $1,668 | $29 |
| Ibuprofen | 12 | $112 | $9 |
2015: 2 drugs
| Hydrocodone-Acetaminophen | 64 | $2,237 | $35 |
| Oxycodone-Acetaminophen | 13 | $827 | $64 |
2014: 4 drugs
| Lidocaine-Prilocaine | 19 | $3,807 | $200 |
| Hydrocodone-Acetaminophen | 131 | $2,744 | $21 |
| Oxycodone-Acetaminophen | 21 | $1,356 | $65 |
| Ibuprofen | 12 | $73 | $6 |
2013: 5 drugs
| Lidocaine-Prilocaine | 15 | $2,773 | $185 |
| Hydrocodone-Acetaminophen | 111 | $1,955 | $18 |
| Oxycodone Hcl-Acetaminophen | 11 | $429 | $39 |
| Carisoprodol | 14 | $95 | $7 |
| Ibuprofen | 16 | $58 | $4 |
Money from drug and device companies
$1,473 in 2025
| 2025 | 2 | 11 | None | $1,473 |
| 2024 | 2 | 2 | None | $35 |
| 2021 | 1 | 2 | None | $1,239 |
| 2019 | 2 | 3 | None | $64 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Arthrex | None | $1,096 | 10 payments
|
| Evolution Surgical | None | $377 | 1 payment
|
See all 11 published payments
| Arthrex | Meals · 2025-06-16 | None | $95 |
| Arthrex | Meals · 2025-06-16 | None | $8 |
| Arthrex | Meals · 2025-06-16 | None | $68 |
| Arthrex | Meals · 2025-06-16 | None | $102 |
| Arthrex | Travel · 2025-06-16 | None | $391 |
| Arthrex | Meals · 2025-06-16 | None | $95 |
| Arthrex | Meals · 2025-06-16 | None | $8 |
| Arthrex | Meals · 2025-06-16 | None | $68 |
| Arthrex | Meals · 2025-06-16 | None | $102 |
| Evolution Surgical | Travel · 2025-05-20 | None | $377 |
| Arthrex | Meals · 2025-04-24 | None | $158 |
See earlier years (2024, 2021, 2019)
2024: $35
| Evolution Surgical | None | $18 | 1 payment
|
| Merck Sharp & Dohme | Bridion | $17 | 1 payment
|
2021: $1,239
| Evolution Surgical | None | $1,239 | 2 payments
|
2019: $64
| Stryker | Variax | $48 | 2 payments
|
| Paragon 28 | None | $15 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1770510117
- Licence
- CA A71570California A71570: Current · expires 2028-04-30
- Trained
- Chicago College of Medicine and Surgery, 1998
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207XX0005X (207XX0005X); Orthopedic surgery (207X00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-06-28
- NPI last updated
- 2024-04-27
- NPI record certified
- 2024-04-27
This is when the NPI record was last certified, not a medical board exam.